Skip to content
We know industry partnerships with patient advocacy organizations are essential to drug R&D—but the industry needs to think beyond traditional partnerships towards engaging with […]
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance
How patient advocates can engage with CMS Read More »
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to President Biden expressing serious concerns with the proposed expansion of a
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden Read More »
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in state capitals, these are busy times for patient advocates working at
State policies impacting access to innovative medicine, panel says Read More »
With the midterm elections less than two weeks away, and a new Congress beginning in just about two months, lobbying and educating Members of
A new Congress is coming. How can patient advocates engage effectively? Read More »
Washington, D.C., is all about who you know—and coalitions of people and groups with the same goals are key to getting stuff done. During
Patient advocacy coalitions can create change – here’s how Read More »
A team of University of Arizona researchers using new knowledge about genes has developed “a drug compound that appears to stop cancer cell growth”
‘Goldilocks drug’ stops triple-negative breast cancer in mice, researchers say Read More »
The Biotechnology Innovation Organization (BIO) kicked off Day One of its two-day Patient and Health Advocacy Summit with a welcome from Eric Dube, President
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit returns to an in-person format for the first time since before the COVID-19 pandemic—and
What to know about the BIO Patient and Health Advocacy Summit Read More »
